Performance vs S&P 500

03
Tracked Q1 2025–Q2 2026 +228.9%
S&P 500 total return (same window) +37.0%
Excess return +191.9%

Annualized: +159.3% · S&P 500: +28.7%

Approximates a buy-and-hold portfolio built from quarterly SEC 13F snapshots. Excludes cash, short positions, options/derivatives, and non-13(f) securities — reflects the disclosed long-equity book only, not total fund AUM. SEC filing lag is up to 45 days; this is not a real-time-copyable timing.

Priceable coverage: 99.9% · Options excluded: 0.0%

Sector breakdown

04
Healthcare 100.0%

Full portfolio 2 positions

05
Type Streak 8Q trend
TYRA Tyra Biosciences, Inc. - Common Stock $122,120,195 95.92% 3,823,425 $-24,316,983
VIR Vir Biotechnology, Inc. - Common Stock $5,196,054 4.08% 509,917 $627,198

Top movers (QoQ)

10
SecurityActionShares ΔValue Δ
TYRA Price move only +0 -$24.3M
VIR Price move only +0 +$627K

Exited positions

11

Includes corporate events (mergers, delistings) — not all exits are sells

Closed positions reflect 13F reporting changes; for index managers these are often mechanical (delisting, M&A, index rebalancing), not active decisions.

SecurityQuarterShares beforeValue beforePrice since exit
ALLK June 30, 2025 2,546,147 $579,503 No longer tracked